144 related articles for article (PubMed ID: 11567771)
1. In vitro processing and presentation of a lipidated cytotoxic T-cell epitope derived from measles virus fusion protein.
Stittelaar KJ; Hoogerhout P; Ovaa W; van Binnendijk RR; Poelen MC; Roholl P; van Els CA; Osterhaus AD; Wiertz EJ
Vaccine; 2001 Oct; 20(1-2):249-61. PubMed ID: 11567771
[TBL] [Abstract][Full Text] [Related]
2. A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.
Herberts CA; Stittelaar KJ; van der Heeft E; van Gaans-van den Brink J; Poelen MCM; Roholl PJM; van Alphen LJW; Melief CJM; de Jong APJM; van Els CACM
J Gen Virol; 2001 Sep; 82(Pt 9):2131-2142. PubMed ID: 11514722
[TBL] [Abstract][Full Text] [Related]
3. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
[TBL] [Abstract][Full Text] [Related]
4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
5. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
[TBL] [Abstract][Full Text] [Related]
7. TAP prefers to transport melanoma antigenic peptides which are longer than the optimal T-cell epitope: evidence for further processing in the endoplasmic reticulum.
Wang Y; Guttoh DS; Androlewicz MJ
Melanoma Res; 1998 Aug; 8(4):345-53. PubMed ID: 9764810
[TBL] [Abstract][Full Text] [Related]
8. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
[TBL] [Abstract][Full Text] [Related]
9. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F
J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639
[TBL] [Abstract][Full Text] [Related]
11. Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.
Johnstone C; Guil S; Rico MA; García-Barreno B; López D; Melero JA; Del Val M
J Gen Virol; 2008 Sep; 89(Pt 9):2194-2203. PubMed ID: 18753229
[TBL] [Abstract][Full Text] [Related]
12. Processing and delivery of peptides presented by MHC class I molecules.
Lehner PJ; Cresswell P
Curr Opin Immunol; 1996 Feb; 8(1):59-67. PubMed ID: 8729447
[TBL] [Abstract][Full Text] [Related]
13. The murine cytomegalovirus pp89 immunodominant H-2Ld epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide.
Knuehl C; Spee P; Ruppert T; Kuckelkorn U; Henklein P; Neefjes J; Kloetzel PM
J Immunol; 2001 Aug; 167(3):1515-21. PubMed ID: 11466372
[TBL] [Abstract][Full Text] [Related]
14. Antigen processing by the class I pathway.
Benham AM; Neefjes JJ
Biochem Soc Trans; 1995 Aug; 23(3):664-9. PubMed ID: 8566439
[No Abstract] [Full Text] [Related]
15. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.
Hallermalm K; Seki K; Wei C; Castelli C; Rivoltini L; Kiessling R; Levitskaya J
Blood; 2001 Aug; 98(4):1108-15. PubMed ID: 11493458
[TBL] [Abstract][Full Text] [Related]
17. Extension of HLA-A*0201-restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells.
Loing E; Andrieu M; Thiam K; Schörner D; Wiesmüller KH; Hosmalin A; Jung G; Gras-Masse H
J Immunol; 2000 Jan; 164(2):900-7. PubMed ID: 10623838
[TBL] [Abstract][Full Text] [Related]
18. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
19. TAP-independent presentation of CTL epitopes by Trojan antigens.
Lu J; Wettstein PJ; Higashimoto Y; Appella E; Celis E
J Immunol; 2001 Jun; 166(12):7063-71. PubMed ID: 11390450
[TBL] [Abstract][Full Text] [Related]
20. Characterization of TAP-independent and brefeldin A-resistant presentation of Sendai virus antigen to CD8+ cytotoxic T lymphocytes.
Zhou X; Liu T; Franksson L; Lederer E; Ljunggren HG; Jondal M
Scand J Immunol; 1995 Jul; 42(1):66-75. PubMed ID: 7631147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
